ANPI Angiotech Pharmaceuticals - Common Shares (MM)

Angiotech Pharmaceuticals to participate in 2005 UBS Global Pharmaceuticals Conference VANCOUVER, May 17 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), is scheduled to participate in the 2005 UBS Global Pharmaceuticals Conference. Tom Bailey, Vice President, Business Development at Angiotech, will be making a 30-minute presentation at the conference on Monday, May 23rd, 2005 at 8:30 AM PDT (11:30 AM EDT). A live audio only webcast of Mr. Bailey's remarks will be available to all interested parties at Angiotech's website at http://www.angiotech.com/ in the Investor Relations section. To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes before the webcast begins. Vancouver-based Angiotech Pharmaceuticals, Inc. is a specialty pharmaceutical company pioneering the combination of pharmaceutical compounds with medical devices and biomaterials to both create novel solutions for poorly addressed disease states and dramatically improve surgical outcomes. To find out more about Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at http://www.angiotech.com/. CONTACTS: Todd Young, Angiotech Pharmaceuticals (Analysts & Investors) (604) 221-7676 ext 6933 Rui Avelar, Angiotech Pharmaceuticals, Inc. (Analysts) (604) 221-7676 ext 6996 Eric Starkman, Starkman & Associates (Media) (212) 252-8545 ext 12 DATASOURCE: Angiotech Pharmaceuticals, Inc. CONTACT: Todd Young, Angiotech Pharmaceuticals, (Analysts & Investors), (604) 221-7676 ext 6933; Rui Avelar, Angiotech Pharmaceuticals, Inc., (Analysts), (604) 221-7676 ext 6996; Eric Starkman, Starkman & Associates, (Media), (212) 252-8545 ext 12

Copyright